Article information
Abstract
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Norway is low, compared to other European and American countries. The health system includes mandatory case reporting and has written guidelines for prevention and control. This communication describes the national public policies related to MRSA obtained from documents and academic experience gained during a doctoral fellowship in Oslo, Norway. The painstaking procedures used for investigating suspected cases, including health professionals, decolonization and case monitoring, could be important tools to be used by countries with a high prevalence of MRSA.
Keywords:
Staphylococcus aureus
resistance to methicillin
hospital infection epidemiological surveillance
Full text is only aviable in PDF
References
[1.]
EARSS. European Antimicrobial Resistance Surveillance System. EARSS. Annual report: 2007. Available on: <http://www.rivm.nl/earss/result/Monitoring_reports/Annual_reports.jsp>. Access on: 25 Jul 2011.
[2.]
Folkehelseinstituttet. Norwegian Institute of Public Health. Surveillance of communicable diseases and nosocomial infections in Norway 2006: trends and main prevention strategies - MRSA. Oslo, 2007.
[3.]
B.M. Andersen, M. Rasch, G. Syversen.
Is an increase of MRSA in Oslo. Norway, associated with changed infection control policy?.
J Infect, 55 (2007), pp. 531-538
[4.]
Ullevål Hospital. Ullevål Standard Guideline. Oslo, 2007.
[5.]
A.E. Fossum, G. Bukholm.
Increased incidence of methicillinresistant Staphylococcus aureus ST80, novel ST125 and SSCmecIV in the south-eastern part of Norway during a 12-year period.
Clin Microb Infect, 12 (2006), pp. 627-633
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
